It has been proposed that FLT3 mutation may be a late event in leukemia, given that FLT3 mutation status are often changed between paired diagnosis and relapse of adult and childhood patients with AML [15-17] or ALL [18]. The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.